Lineage Cell Therapeutics (LCTX) EBIT Margin (2010 - 2026)
Lineage Cell Therapeutics (LCTX) recorded EBIT Margin of -834.71% in Q2 2026, down 119.33 percentage points from -715.37% a year earlier and down 394.53 percentage points from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) EBIT Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Lineage Cell Therapeutics' EBIT Margin came in at -205.23% as of Jun 30, 2026, up 117.61 percentage points year-over-year; for FY2025, it came in at -251.57%, down 25.47 percentage points from FY2024.
- Annual EBIT Margin has a five-year change of +1196.78 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at -226.11% in FY2024 (+50.39 pp), -276.50% in FY2023 (-123.33 pp), -153.17% in FY2022 (+980.47 pp) and -1133.63% in FY2021 (+314.72 pp).
- The Q2 2026 figure is the lowest quarterly EBIT Margin since Q4 2021.
- On a year-over-year basis, EBIT Margin rose in four of the last eight quarters, with an average year-over-year change of +30.50 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 2070.95 percentage points in Q4 2022, against a drop of 760.74 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -440.17% (Q1 2026), -99.09% (Q4 2025) and -102.85% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | -834.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -834.71% |
| Mar 31, 2026 | -440.17% |
| Dec 31, 2025 | -99.09% |
| Sep 30, 2025 | -102.85% |
| Jun 30, 2025 | -715.37% |
| Mar 31, 2025 | -433.09% |
| Dec 31, 2024 | -178.17% |
| Sep 30, 2024 | -101.61% |
| Jun 30, 2024 | -416.69% |
| Mar 31, 2024 | -461.29% |
| Dec 31, 2023 | -304.69% |
| Sep 30, 2023 | -538.12% |
| Jun 30, 2023 | -155.78% |
| Mar 31, 2023 | -278.37% |
| Dec 31, 2022 | -346.68% |
| Sep 30, 2022 | -175.15% |
| Jun 30, 2022 | -92.99% |
| Mar 31, 2022 | -122.13% |
| Dec 31, 2021 | -2,417.64% |
| Sep 30, 2021 | -301.45% |
API Access
Lineage Cell Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();